Integrating germline and somatic data towards a personalized cancer medicine

Trends in Molecular Medicine

Volumn 20, Issue 8, 2014, Pages 413-415

  Pujana, Miguel Angel ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Cancer; Genetics; Germline; Personalized medicine; Risk; Somatic

Indexed keywords

CANCER SUSCEPTIBILITY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GERMLINE MUTATION; HUMAN; MOLECULAR GENETICS; NEOPLASM; NONHUMAN; NOTE; PERSONALIZED MEDICINE; SOMATIC MUTATION; GENETICS; NEOPLASMS; PATHOLOGY; PROCEDURES;

GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; INDIVIDUALIZED MEDICINE; NEOPLASMS;

EID: 84905049500     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2014.05.004     Document Type: Note

References (15)

1. Varghese J.S., Easton D.F. Genome-wide association studies in common cancers - what have we learnt?. Curr. Opin. Genet. Dev. 2010, 20:201-209.
2. Michailidou K., et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. 2013, 45:353-361.
3. Garcia-Closas M., et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat. Genet. 2013, 45:392-398.
4. Hartman M., et al. Is breast cancer prognosis inherited?. Breast Cancer Res. 2007, 9:R39.
5. Hsieh S.M., et al. Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study. Breast Cancer Res. 2009, 11:R75.
6. Azzato E.M., et al. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. J. Natl. Cancer Inst. 2010, 102:650-662.
7. Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70. Cancer Genome Atlas Network.
8. Curtis C., et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012, 486:346-352.
9. Vogelstein B., et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988, 319:525-532.
10. Turnbull C., et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat. Genet. 2010, 42:504-507.
11. Pomerantz M.M., et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat. Genet. 2009, 41:882-884.
12. Menashe I., et al. Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Res. 2010, 70:4453-4459.
13. Rafnar T., et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat. Genet. 2009, 41:221-227.
14. Barnes D.R., Antoniou A.C. Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers. J. Intern. Med. 2012, 271:331-343.
15. Rozenblatt-Rosen O., et al. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature 2012, 487:491-495.